Drawing for OUTRUNNING CANCER

USPTO serial 88084711

OUTRUNNING CANCER

Reviewed by CopyMark Law Group

Reg. 5726723Status 702Registered
Filing date
Status date
Registration date
Apr 16, 2019
Examiner
RINKER, ANTHONY MICHAEL
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with OUTRUNNING CANCER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kelley Bregenzer

Kelley Bregenzer ND Galli Law LLC1650 Market Street Suite 3600One Liberty SquarePhiladelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
036Charitable fundraising services; Charitable fundraising services for promoting research, education and other activities relating to metastatic cancer; Charitable foundation services, namely, providing fundraising activities to support medical research and procedures for those in need; Charitable fundraising services by means of running and walking eventsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 18, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 18, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 10, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jan 16, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 16, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 16, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 16, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 16, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 29, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 29, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 9, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 26, 2018ALIEASSIGNED TO LIE—
Dec 5, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 5, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Dec 5, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 5, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 5, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 5, 2018DOCKASSIGNED TO EXAMINER—
Aug 28, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 23, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance